Company Update

Pure Malaysia obtains its MDA Establishment licence

Malaysia, a key gateway to Southeast Asia, offers strategic access for businesses. Understanding medical device regulations is crucial for market entry.

Published on:
April 22, 2024

Malaysia is centrally located within Southeast Asia, and is an ideal regional gateway for overseas companies to venture into Southeast Asia. In the north, Perlis, Kedah, Perak and Kelantan share a border with Thailand and people on either side speak both Thai and Malay. In Sabah, the Malay diaspora extends to the southern part of the Philippines which has aporous border. Malaysia also shares a land border with Indonesia and Brunei in the island of Borneo. In the South, its border with Singapore allows thousands of people to commute each day for work and trade.

The Malaysian medical device market is an important one, given its significant size and potential for growth. However, before medical devices can be marketed and sold in Malaysia, they must be registered with the Malaysian Medical Device Authority (MDA) and comply with the country's regulatory requirements, to ensure that products are safe, effective, and of high quality.

For companies to register and hold MDA medical device certs, they must first obtain what is known as an “Establishment licence”, of which the detailed requirements are specified under Section 15 of the Medical Device Act 2012 (Act 737). All establishments as defined in Section 2 of the Act 737 shall obtain a license/licenses before they can import, export or place a medical device in the market.

Pure Malaysia is now able to act as your Authorized Representative (AR) in Malaysia. By having a neutral third party such as Pure Global hold your MDA medical device licence, you can easily switch distributors immediately without the hassle of re-registering your product with MDA which may take 6 months or more.

Contact us for a non-obligatory discussion today!

Subscribe to newsletter
Subscribe to receive the latest blog posts to your inbox every week.
By subscribing, you agree to our Terms and Conditions.
Thank you for subscribing!
Oops! Something went wrong while submitting the form.
Read more

Latest News

Browse our news hub featuring company announcements, regulatory updates, and industry insights to keep you informed and ahead of the curve.

Regulatory Update
January 29, 2025

Wrapping up January 2025, medical device regulatory developments include new forms for NBs in Europe, new PMS guidance in the UK, an expedited approval partnership between China and Malaysia, and warnings of supply chain disruptions for pediatric patients in the US.

Regulatory Update
January 23, 2025

Medical device regulatory developments from the US and Thailand include: final FDA guidance on modular review for premarket approval applications and humanitarian device exemptions, and new expedited regulatory routes for low-risk devices and chronic disease prevention devices in Thailand.

Regulatory Update
January 16, 2025

This week, we are reporting on medical device regulatory updates from Canada, Europe, Brazil, and China. China's NMPA released registration review timelines, clarification on MDR and IVDR vigilance terms is now available, and Health Canada updated validation rules for non-eCTD transactions.

To kick off 2025, we bring you a round up of medical device regulatory updates from across Europe and the US, including a new position paper from TEAM-NB on MDR certification processes and numerous guidance updates from the US FDA.

Contact us
Request information

Let's Talk,
Anywhere You Are.

Whether looking for more information or ready to partner with us, we're here to guide you through every step of the regulatory process.

Our closest representative will get back to you within 24 hours.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Latest Blog Content

Explore our collection of articles, success stories, and regulatory updates, designed to help you take your product global.

Blog Article

The official IVDR transition period is here. IVDR expert Dr. Oliver Eikenberg discusses how IVD manufacturers should take action, starting with how to implement IVDR QMS requirements for the May 2025 deadline.

Kuala Lumpur Malaysia Skyline
Blog Article
Pure Global Team attends IMDEC 2024 in Malaysia

Pure Global participated in IMDEC 2024 in Kuala Lumpur to discuss the latest advancements in medical technology, regulatory efficiency, and the role of AI in transforming the industry. Highlights included updates from the Malaysian Medical Device Authority (MDA) that showcased their commitment to driving regional leadership in medical device regulation and innovation.

Pure Global 2024 Year in Review
Blog Article
Pure Global 2024 Year in Review

As 2024 comes to a close, Pure Global proudly reflects on a transformative year marked by substantial growth, cutting-edge innovation, and impactful collaborations.

Risk increases compliance chalenges under IVDR
Blog Article
What are the challenges under IVDR?

IVD manufacturers cite the new classification system, detailed definitions for intended purposes, and the need for verification of clinical evidence as key challenges under the IVDR.